Senior Director, Omnichannel & Digital Engagement at Dyno Therapeutics

Waltham, Massachusetts, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Pharmaceuticals, HealthcareIndustries

Requirements

Bachelor’s degree required; advanced degree in Digital Marketing, Communications, Life Sciences, or related field preferred
12+ years of experience in biotech/pharma, including 8+ years in digital marketing and omnichannel strategy; experience in another industry is a plus
Proven track record of developing and executing omnichannel strategies for both HCP and patient audiences
Deep understanding of CRM, content orchestration, and marketing automation platforms (e.g., SFMC)
Launch experience in pharma/biotech required, including familiarity with MLR/PRC processes and regulatory considerations
Knowledge of global data privacy regulations and compliance
Experience in rare disease preferred
Ability to thrive in a fast-paced, dynamic environment and manage multiple priorities
Minimal travel expected

Responsibilities

Develop and execute a comprehensive omnichannel strategy in partnership with the Head of Commercialization, CDIO, and IT, embedded within Dyne’s broader launch preparedness and commercialization plans
Serve as Dyne’s subject matter expert and change agent for digital-first engagement, championing innovative programs across HCP and patient/caregiver channels
Lead omnichannel planning and execution across web, CRM, mobile, email, social, search, live/virtual events, and field-triggered channels
Partner with external agencies and vendors to deliver high-impact omnichannel tactics
Collaborate with Commercial, Medical, Advocacy, and Corporate Communications teams to translate unbranded and branded content into integrated digital engagement plans
Retrofit existing platforms and content to align with omnichannel strategy and ensure seamless integration across functions
Establish a robust performance tracking and analytics framework to measure channel effectiveness, field feedback, and inform data-driven optimization
Manage associated budgets and ensure compliance with Dyne’s financial processes
Stay current on industry trends, emerging technologies, and best practices to inform strategic planning and operational improvements

Skills

Key technologies and capabilities for this role

Omnichannel StrategyDigital EngagementMarketing PlanningPerformance MeasurementCross-Functional CollaborationHCP EngagementPatient EngagementCommercializationLaunch PreparednessAnalyticsIT Collaboration

Questions & Answers

Common questions about this position

Is this role remote or based in a specific location?

This role is based in Waltham, MA.

What are the key skills required for this position?

This information is not specified in the job description.

What is the salary or compensation for this role?

This information is not specified in the job description.

What does the company culture or work environment look like at Dyne Therapeutics?

This information is not specified in the job description.

What makes a strong candidate for this Senior Director role?

A strong candidate should have expertise in developing and executing omnichannel strategies, leading digital engagement across multiple channels, and collaborating cross-functionally with teams like IT, Marketing, and Commercial Operations.

Dyno Therapeutics

Develops AI-optimized gene therapy vectors

About Dyno Therapeutics

Dyno Therapeutics focuses on advancing gene therapy by utilizing Artificial Intelligence to create Adeno-associated virus (AAV) vectors. These vectors are essential tools for delivering genetic material into cells, which is crucial for effective gene therapy. The company's AI technology enables the design and optimization of these vectors, potentially enhancing the success of gene therapies. Dyno collaborates with major pharmaceutical and biotech companies, such as Astellas, Roche, Sarepta, and Novartis, to develop therapies for various diseases affecting the skeletal and cardiac muscles, central nervous system, liver, and eyes. Unlike many competitors, Dyno's unique approach leverages AI to improve the performance of AAV vectors, setting it apart in the biotech field. The company's goal is to improve gene therapy outcomes through its advanced vector technology, ultimately benefiting patients with serious health conditions.

Watertown, MassachusettsHeadquarters

2018Year Founded

$106MTotal Funding

SERIES_ACompany Stage

AI & Machine Learning, Biotechnology, HealthcareIndustries

51-200Employees

Benefits

Remote Work Options

Risks

Gene therapy investment slowdown may impact Dyno's growth and innovation.

Manufacturing bottlenecks could hinder scaling of Dyno's operations.

Increased competition from companies like Form Bio challenges Dyno's market position.

Differentiation

Dyno uses AI to design optimized AAV vectors for gene therapy.

Their AI-driven CapsidMap platform enhances AAV vector development for muscle gene therapies.

Partnerships with major pharma companies like Astellas and Roche boost Dyno's market presence.

Upsides

AI-driven capsid design improves delivery efficiency and reduces manufacturing costs.

Collaboration with NVIDIA enhances biological sequence design for gene therapies.

Generative AI increases efficiency of eye and brain-targeted capsid delivery significantly.

Land your dream remote job 3x faster with AI

Try Jobo Free